Literature DB >> 24170257

A novel mutation in STXBP1 gene in a child with epileptic encephalopathy and an atypical electroclinical pattern.

Romina Romaniello1, Claudio Zucca, Erika Tenderini, Filippo Arrigoni, Francesca Ragona, Giovanna Zorzi, Maria Teresa Bassi, Renato Borgatti.   

Abstract

Mutations in STXBP1 gene, encoding the syntaxin binding protein 1, have been recently described in Ohtahara syndrome, or early infantile epileptic encephalopathy with suppression-burst pattern, and in other early-onset epileptic encephalopathies. A 3-year-old boy affected by epileptic encephalopathy started at 8 months of age is described. Focal epilepsy was characterized by drug resistance seizures with multifocal interictal and ictal electroencephalographic (EEG) features and variable EEG focus. Direct sequencing of the STXBP1 gene showed a novel de novo mutation (c.751G>A), leading to a p.Ala251Thr substitution. Based on reported data, treatment with vigabatrin was attempted and patient became immediately seizure free for 4 months. The present case further expands the clinical spectrum of "STXBP1-related encephalopathy" suggesting molecular analysis of STXBP1 in early onset epileptic encephalopathies of unknown etiology (with onset within the first year of life). In addition, the case provides valuable suggestions on seizures treatment in STXBP1 mutated subjects.

Entities:  

Keywords:  STXBP1 gene; Ohtahara syndrome; epilepsy; epileptic encephalopathy; vigabatrin therapy

Mesh:

Substances:

Year:  2013        PMID: 24170257     DOI: 10.1177/0883073813506936

Source DB:  PubMed          Journal:  J Child Neurol        ISSN: 0883-0738            Impact factor:   1.987


  7 in total

Review 1.  Epileptic encephalopathies: new genes and new pathways.

Authors:  Sahar Esmaeeli Nieh; Elliott H Sherr
Journal:  Neurotherapeutics       Date:  2014-10       Impact factor: 7.620

2.  STXBP1 encephalopathies: Clinical spectrum, disease mechanisms, and therapeutic strategies.

Authors:  Debra Abramov; Noah Guy Lewis Guiberson; Jacqueline Burré
Journal:  J Neurochem       Date:  2020-08-04       Impact factor: 5.372

3.  Epilepsy Course and Developmental Trajectories in STXBP1-DEE.

Authors:  Ganna Balagura; Julie Xian; Antonella Riva; Francesca Marchese; Bruria Ben Zeev; Loreto Rios; Deepa Sirsi; Patrizia Accorsi; Elisabetta Amadori; Guja Astrea; Simona Baldassari; Francesca Beccaria; Antonella Boni; Mauro Budetta; Gaetano Cantalupo; Giuseppe Capovilla; Elisabetta Cesaroni; Valentina Chiesa; Antonietta Coppola; Robertino Dilena; Raffaella Faggioli; Annarita Ferrari; Elena Fiorini; Francesca Madia; Elena Gennaro; Thea Giacomini; Lucio Giordano; Michele Iacomino; Simona Lattanzi; Carla Marini; Maria Margherita Mancardi; Massimo Mastrangelo; Tullio Messana; Carlo Minetti; Lino Nobili; Amanda Papa; Antonia Parmeggiani; Tiziana Pisano; Angelo Russo; Vincenzo Salpietro; Salvatore Savasta; Marcello Scala; Andrea Accogli; Barbara Scelsa; Paolo Scudieri; Alberto Spalice; Nicola Specchio; Marina Trivisano; Michal Tzadok; Massimiliano Valeriani; Maria Stella Vari; Alberto Verrotti; Federico Vigevano; Aglaia Vignoli; Ruud Toonen; Federico Zara; Ingo Helbig; Pasquale Striano
Journal:  Neurol Genet       Date:  2022-05-31

4.  Protein structure and phenotypic analysis of pathogenic and population missense variants in STXBP1.

Authors:  Mohnish Suri; Jochem M G Evers; Roman A Laskowski; Sinead O'Brien; Kate Baker; Jill Clayton-Smith; Tabib Dabir; Dragana Josifova; Shelagh Joss; Bronwyn Kerr; Alison Kraus; Meriel McEntagart; Jenny Morton; Audrey Smith; Miranda Splitt; Janet M Thornton; Caroline F Wright
Journal:  Mol Genet Genomic Med       Date:  2017-06-20       Impact factor: 2.183

5.  Clemizole and trazodone are effective antiseizure treatments in a zebrafish model of STXBP1 disorder.

Authors:  Maia Moog; Scott C Baraban
Journal:  Epilepsia Open       Date:  2022-05-17

6.  Confirming the contribution and genetic spectrum of de novo mutation in infantile spasms: Evidence from a Chinese cohort.

Authors:  Liying Liu; Fang Liu; Qiuhong Wang; Hua Xie; Zhengchang Li; Qian Lu; Yangyang Wang; Mengna Zhang; Yu Zhang; Jonathan Picker; Xiaodai Cui; Liping Zou; Xiaoli Chen
Journal:  Mol Genet Genomic Med       Date:  2021-05-05       Impact factor: 2.183

7.  Developing a PPI inhibitor-based therapy for STXBP1 haploinsufficiency-associated epileptic disorders.

Authors:  Shobbir Hussain
Journal:  Front Mol Neurosci       Date:  2014-02-04       Impact factor: 5.639

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.